Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学HR+ Breast Clinical Trials

Debu Tripathy

MD

🏢MD Anderson Cancer Center🌐USA

Professor and Chair, Breast Medical Oncology

61
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Debu Tripathy chairs Breast Medical Oncology at MD Anderson and has led multiple pivotal clinical trials in HR-positive metastatic breast cancer. He was an investigator on the MONALEESA trials establishing ribociclib combined with endocrine therapy as standard of care. His research spans endocrine therapy sequencing, resistance mechanisms, and novel targeted agents for advanced HR+ disease.

Share:

🧪Research Fields 研究领域

HR+ breast cancer clinical trials
CDK4/6 inhibitors metastatic
endocrine therapy resistance
ribociclib clinical development
breast cancer advanced disease

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Debu Tripathy 的研究动态

Follow Debu Tripathy's research updates

留下邮箱,当我们发布与 Debu Tripathy(MD Anderson Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment